MoneyWorks4Me

Ravelcare Ltd (544629)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544629 NSE: Trading | Small Cap | Ravelcare Share Price

₹102 0.75 (0.74%)

As on 18-Sep'26 12:27

Ravelcare Ltd (544629)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544629 NSE: Trading | Small Cap | Ravelcare Share Price

₹102 0.75 (0.74%)

As on 18-Sep'26 12:27

Key Metrics
Valuation Multiples
Market Cap
₹69 Cr.
Current Price
₹102
52-Week Low / High
₹100 / 215
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
38.6
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
13.08%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
72.94%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹6.9 Cr.
Face Value
₹10
All Time Low / High
₹100.00 / 215.00

Ravelcare stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Ravelcare Ltd a good quality company?
Ravelcare Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Ravelcare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Ravelcare Ltd vs industry peers?
Ravelcare Ltd revenue CAGR is %, compared to the industry median CAGR of 0.00%, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of Ravelcare Ltd?
Promoters hold 72.94% of the Ravelcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Ravelcare Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Ravelcare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -1,322.4%206.1%246.2%91.4%-
Value Creation
Index
NA13.716.65.5-

Growth Parameters

Sales 0.83.522.12527
Sales YoY Gr.-341.8%533%13.1%-
Adj EPS -0.60.81010.47.5
YoY Gr.-NA1109.6%3.8%-
BVPS (₹) -0.80.110.220.750.2
Adj Net
Profit
-0.30.455.25
Cash Flow from Ops. -0.416.4-0.6-
Debt/CF from Ops. -10.400-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA216.2%13.1%
Adj EPS NANANA3.8%
BVPSNANANA103.1%
Share Price - - - -

Key Financial Parameters

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
70.4-253.2194.467.621.2
Op. Profit
Mgn %
-27.614.630.527.5NAN
Net Profit
Mgn %
-35.711.922.820.919.1
Debt to
Equity
-15.600-
Working Cap
Days
042751260
Cash Conv.
Cycle
016-10170

Valuation of Ravelcare - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

data not found
No data found!
data
No data found!
data
No data found!
data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ravelcare Ltd FAQs

The current trading price of Ravelcare on 18-Sep-2026 12:27 is ₹102.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Sep-2026 the market cap of Ravelcare stood at ₹69.45 Cr

The latest P/E ratio of Ravelcare as of 17-Sep-2026 is 13.47.

The latest P/B ratio of Ravelcare as of 17-Sep-2026 is 2.02.

The 52-week high of Ravelcare is ₹215.0 and the 52-week low is ₹100.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ravelcare is ₹26.95 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Ravelcare Ltd is a below average quality company.

The key valuation ratios of Ravelcare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Ravelcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Ravelcare Ltd

Ravelcare Limited was originally incorporated and registered as a private limited company in the name and style of ‘Ravelcare Private Limited’ on November 29, 2018. Pursuant to a resolution of the Board dated March 22, 2024 and a resolution of the shareholders dated March 27, 2024, the company was converted into a public limited company and consequently the name of the company was changed to ‘Ravelcare Limited’ on June 14, 2024.

The company operates through a digital first distribution model in the beauty and personal care segment (BPC) offering a range of haircare, skincare, and bodycare products. The products are sold through multiple channels including its website, major online marketplaces such as Amazon, Flipkart and Myntra and quick commerce platform i.e. Blinkit. Its business model focuses on leveraging e-commerce platforms and digital channels to engage with customers directly through its product offering. The company aims to leverage technology to streamline customer engagement, demand forecasting, and fulfilment, forming an essential part of its digital-first platform. It also focuses on providing personalized experience through customized haircare and skincare products. 

Its manufacturing is undertaken through contract manufacturing arrangement with licensed third-party contract manufacturer. The formulations of the products are developed by the company and the product Research and Development (R&D) is carried out in collaboration with external formulation experts and third-party laboratories. The company also manages logistics and warehousing operations across key Indian states to ensure timely delivery and supply chain reliability.

Business area of the company 

The company is engaged in the trading of variety of Personal Care Products such as Haircare, Skincare, Body care and other related products through its own website and other E-Commerce platform such as Amazon, Flipkart which are manufactured through third party manufacturers under the brand name of ‘Ravel’.

Products of the company

  • Haircare Products: Its haircare segment includes shampoos, conditioners, hair masks, hair oils, and styling products.
  • Skincare Products: Its skincare range consists of face cleansers, serums, moisturizers, sunscreens, and concern-specific treatments.
  • Bodycare Products: Its bodycare segment includes products such as body washes and body lotions.
  • Scalp Care Products: Its Scalp care product range contains anti-dandruff scalp tonic, hair growth serum which are launched and live and hair fall control scalp ampoules for which necessary approvals are received.

Awards, accreditations and recognition

  • The company had featured on Shark Tank Season 2 in the year 2022.

You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now